A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components

CompletedOBSERVATIONAL
Enrollment

2,291

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

September 30, 2020

Study Completion Date

May 31, 2021

Conditions
Transfusion Related Acute Lung Injury
Interventions
OTHER

Standard of Care

Trial Locations (15)

10065

Memorial Sloan Kettering, New York

14263

Roswell Park Cancer Institute, Buffalo

14642

Strong Memorial Hospital, Rochester

21201

University of Maryland, Baltimore

27705

Duke University Medical Center, Durham

27834

East Carolina University Hospital, Greenville

30322

Emory University, Atlanta

37212

Vanderbilt University Medical Center, Nashville

45220

TriHealth Cancer Institute, Cincinnati

55455

University of Minnesota, Minneapolis

63110

St. Louis Children's Hospital, St Louis

90095

UCLA Medical Center, Los Angeles

94305

Stanford University, Palo Alto

06520

Yale-New Haven Hospital, New Haven

02215

Beth Israel, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cerus Corporation

INDUSTRY